Raymond James & Associates’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.13M | Sell |
|
|||||
|
2024
Q2 | $1.12M | Buy |
|
|||||
|
2024
Q1 | $555K | Buy |
|
|||||
|
2023
Q4 | $404K | Buy |
|
|||||
|
2023
Q3 | $390K | Buy |
|
|||||
|
2023
Q2 | $322K | Sell |
|
|||||
|
2023
Q1 | $521K | Sell |
|
|||||
|
2022
Q4 | $2.33M | Buy |
|
|||||
|
2022
Q3 | $901K | Buy |
|
|||||
|
2022
Q2 | $1.03M | Buy |
|
|||||
|
2022
Q1 | $912K | Buy |
|
|||||
|
2021
Q4 | $792K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $264K | Sell |
|
|||||
|
2021
Q1 | $250K | Sell |
|
|||||
|
2020
Q4 | $245K | Sell |
|
|||||
|
2020
Q3 | $267K | Hold |
|
|||||
|
2020
Q2 | $267K | Buy |
|
|||||
|
2020
Q1 | $229K | Buy |
|
|||||
|
2019
Q4 | $232K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $310K | Hold |
|
|||||
|
2018
Q4 | $279K | Sell |
|
|||||
|
2018
Q3 | $5.74M | Sell |
|
|||||
|
2018
Q2 | $5.4M | Sell |
|
|||||
|
2018
Q1 | $5.24M | Buy |
|
|||||
|
2017
Q4 | $5.43M | Buy |
|
|||||
|
2017
Q3 | $5.11M | Sell |
|
|||||
|
2017
Q2 | $5.76M | Buy |
|
|||||
|
2017
Q1 | $5.36M | Buy |
|
|||||
|
2016
Q4 | $4.99M | Buy |
|
|||||
|
2016
Q3 | $5.32M | Buy |
|
|||||
|
2016
Q2 | $5.19M | Buy |
|
|||||
|
2016
Q1 | $4.41M | Buy |
|
|||||
|
2015
Q4 | $5M | Buy |
|
|||||
|
2015
Q3 | $4.81M | Sell |
|
|||||
|
2015
Q2 | $5.56M | Sell |
|
|||||
|
2015
Q1 | $5.53M | Sell |
|
|||||
|
2014
Q4 | $5.23M | Sell |
|
|||||
|
2014
Q3 | $5.23M | Sell |
|
|||||
|
2014
Q2 | $6.13M | Buy |
|
|||||
|
2014
Q1 | $4.69M | Buy |
|